Investing.com - Financial Markets Worldwide

Medite Cancer Diagnostics Inc (MDIT)

OTC Markets
Currency in USD
0.000001
0.000000(0.00%)
Closed·
MDIT Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
Fair Value
Unlock Value
Day's Range
0.0000010.000001
52 wk Range
0.0000010.000100
Key Statistics
Edit
Prev. Close
0.000001
Open
0.000001
Day's Range
0.000001-0.000001
52 wk Range
0.000001-0.0001
Volume
-
Average Volume (3m)
15.63K
1-Year Change
-99%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDIT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Suffers from weak gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Medite Cancer Diagnostics Inc Company Profile

Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
69
Market
United States

Compare MDIT to Peers and Sector

Metrics to compare
MDIT
Peers
Sector
Relationship
P/E Ratio
0.0x−3.7x−0.5x
PEG Ratio
0.00−0.240.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x3.1x3.3x
Upside (Analyst Target)
0.0%42.1%43.5%
Fair Value Upside
Unlock3.5%6.3%Unlock

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

MDIT Income Statement

FAQ

What Stock Exchange Does Medite Trade On?

Medite is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Medite?

The stock symbol for Medite is "MDIT."

What Is the Medite Market Cap?

As of today, Medite market cap is 85.81.

What Is Medite's Earnings Per Share (TTM)?

The Medite EPS (TTM) is -0.11.

From a Technical Analysis Perspective, Is MDIT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medite Stock Split?

Medite has split 2 times.

How Many Employees Does Medite Have?

Medite has 69 employees.

What is the current trading status of Medite (MDIT)?

As of 05 Aug 2025, Medite (MDIT) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.